Rate of progression in Alzheimer's disease correlates with coated-platelet levels-a longitudinal study

Translational Research

Volumn 152, Issue 3, 2008, Pages 99-102

  Prodan, Calin I ^a   Ross, Elliott D ^a   Vincent, Andrea S ^a   Dale, George L ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; COLLAGEN; THROMBIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COATED PLATELET LEVEL; CORRELATIONAL STUDY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; LONGITUDINAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MONITORING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THROMBOCYTE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; BLOOD PLATELETS; BRIEF PSYCHIATRIC RATING SCALE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PLATELET ACTIVATION; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURFACE PROPERTIES;

EID: 51749090449     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2008.07.001     Document Type: Article

References (15)

1. Dale G.L. Coated-platelets: an emerging component of the procoagulant response. J Thromb Haemost 3 (2005) 2185-2192
2. Prodan C.I., Szasz R., Vincent A.S., Ross E.D., and Dale G.L. Coated-platelets retain amyloid precursor protein on their surface. Platelets 17 (2005) 56-60
3. Prodan C.I., Ross E.D., Vincent A.S., and Dale G.L. Coated-platelets correlate with disease progression in Alzheimer disease. J Neurol 254 (2007) 548-549
4. Prodan C.I., Ross E.D., Vincent A.S., and Dale G.L. Coated-platelets are higher in amnestic versus non-amnestic patients with mild cognitive impairment. Alzheimer Dis Assoc Disord 21 (2007) 259-261
5. Petersen R.C. Mild cognitive impairment: current research and clinical implications. Semin Neurol 27 (2007) 22-31
6. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
7. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state.". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
8. Manolio T.A., Kronmal R.A., Burke G.L., et al. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke 25 (1994) 318-327
9. Prodan C.I., Joseph P.M., Vincent A.S., and Dale G.L. Coated-platelet levels are influenced by smoking, aspirin and selective serotonin reuptake inhibitors. J Thromb Haemost 5 (2007) 2149-2151
10. Davies T.A., Long H.J., Sgro K., et al. Activated Alzheimer disease platelets retain more beta amyloid precursor protein. Neurobiol Aging 18 (1997) 147-153
11. Baskin F., Rosenberg R.N., Iyer L., Hynan L., and Cullum C.M. Platelet APP isoform ratios correlate with declining cognition in AD. Neurology 54 (2000) 1907-1909
12. Borroni B., Colciaghi F., Archetti S., et al. Predicting cognitive decline in Alzheimer disease-role of platelet amyloid precursor protein. Alzheimer Dis Assoc Dis 18 (2004) 32-34
13. Borroni B., Di Luca M., and Padovani A. Predicting Alzheimer dementia in mild cognitive impairment patients-are biomarkers useful?. Eur J Pharmacol 545 (2006) 73-80
14. Tang K., Hynan L.S., Baskin F., and Rosenberg R.N. Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease. J Neurol Sci 240 (2006) 53-58
15. Masters C.L., and Beyreuther K. Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway. Brain 129 (2006) 2823-2839